ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Genor Biopharma (6998.HK)
Genor Biopharma share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$1.60▼ -1.85%
Prices as of Oct 26, 2026 · HKD
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Genor Biopharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Genor Biopharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Genor Biopharma a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$1.43 and HK$1.75; in 9 out of 10, between HK$1.20 and HK$2.09. Estimated annual volatility is 53%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$3.2B
- Market cap (USD)
- $413M
- P/E ratio
- 10.3
- 52-week high
- HK$3.90
- 52-week low
- HK$1.42
- Revenue (12 months)
- CN¥2.2B
- Gross margin
- 68.0%
- Operating margin
- 11.3%
- Net margin
- 9.8%
- Beta
- 0.99
What this means
ATLAS does not publish a fair value for 6998.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 6998.HK has traded between HK$1.42 and HK$3.90. Today it is 59.1% below that high and 12% above its low.
On the business: net margin is 9.8%; it trades at 10.3 times earnings.
Its beta is 0.99: it moves roughly in line with the market.
About the company
Edding Genor Group Holdings Limited, together with its subsidiaries, engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally.
Want to see everything about Genor Biopharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Genor Biopharma do?
Edding Genor Group Holdings Limited, together with its subsidiaries, engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally.
What is the chance 6998.HK goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, 6998.HK ends the month between HK$1.43 and HK$1.75.
How big is Genor Biopharma and what is its P/E ratio?
Genor Biopharma's market capitalization is HK$3.2B. Its price-to-earnings (P/E) ratio is 10.3: you pay HK$10.3 for each HK$1.00 of yearly earnings.
How volatile is 6998.HK?
ATLAS estimates annual volatility at 53%. In a typical month, half of the outcomes end between HK$1.43 and HK$1.75.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer